retatrutide triple agonist obesity hormone receptor clinical trial results Retatrutide (Triple-Action Jab): Phase III retatrutide #obesity #osteoarthritis #clinicaltrials #medicine
Description
GLP-1 medications are often used in patients with chronic kidney disease, and caution is warranted
Expert insights on health, wellness, and modern care
A large cohort found former smokers had lower risk of myocardial infarction and stroke than continuing smokers, irrespective of post-cessation weight changes []
& Barofsky, I
When available, pricing varies but generally falls within similar ranges to injectable compounded options
What they found: Dose-dependent stimulation of type II collagen (up to 2.5 baseline at 100 nM) Stimulation of aggrecan (up to 1.8 baseline) Inhibition of MMP-13 by ~40 % Partial protection against IL-1-induced matrix degradation Why it matters: It opened a completely new research area for AOD-9604 beyond lipolysis
